Suche
Mein Konto
BASF expert opinion: There are no real signs of recovery in the short term
According to a report from www.4investors.de, the macroeconomic environment remains difficult for BASF. Deutsche Bank analysts see no signs of a recovery in this area in the short term. Nevertheless, there was positive news from BASF regarding investments, the dividend and the stake in Wintershall DEA. The Capital Markets Day was also well received. The analysts therefore confirm the buy recommendation for BASF shares and still see the price target at EUR 54.00. However, not all experts are so optimistic. Bernstein confirmed the “underperform” rating for BASF’s shares and calculated a price target of EUR 39.00. They advise investors not to buy...
BASF expert opinion: There are no real signs of recovery in the short term
According to a report by www.4investors.de, the macroeconomic environment remains difficult for BASF. Deutsche Bank analysts see no signs of a recovery in this area in the short term. Nevertheless, there was positive news from BASF regarding investments, the dividend and the stake in Wintershall DEA. The Capital Markets Day was also well received. The analysts therefore confirm the buy recommendation for BASF shares and still see the price target at EUR 54.00.
However, not all experts are so optimistic. Bernstein confirmed the “underperform” rating for BASF’s shares and calculated a price target of EUR 39.00. You are currently advising investors against buying BASF shares.
BASF's share price is currently 45.10 euros, which corresponds to an increase of 0.2 percent.
Due to the difficult macroeconomic environment and the different assessments of experts, this could lead to increased volatility in the share price and uncertainty among investors. Investors should continue to closely monitor the performance of BASF shares in order to make informed decisions.
Read the source article at www.4investors.de